Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Return on Equity (2018 - 2024)

Historic Return on Equity for Solid Biosciences (SLDB) over the last 7 years, with Q3 2024 value amounting to 0.57%.

  • Solid Biosciences' Return on Equity rose 1400.0% to 0.57% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.57%, marking a year-over-year increase of 1400.0%. This contributed to the annual value of 0.57% for FY2023, which is 800.0% down from last year.
  • Solid Biosciences' Return on Equity amounted to 0.57% in Q3 2024, which was up 1400.0% from 0.45% recorded in Q2 2024.
  • Over the past 5 years, Solid Biosciences' Return on Equity peaked at 0.09% during Q3 2021, and registered a low of 3.14% during Q3 2020.
  • Moreover, its 5-year median value for Return on Equity was 0.55% (2023), whereas its average is 0.81%.
  • As far as peak fluctuations go, Solid Biosciences' Return on Equity crashed by -19800bps in 2020, and later soared by 30500bps in 2021.
  • Quarter analysis of 5 years shows Solid Biosciences' Return on Equity stood at 1.14% in 2020, then skyrocketed by 92bps to 0.09% in 2021, then crashed by -378bps to 0.44% in 2022, then crashed by -62bps to 0.72% in 2023, then rose by 20bps to 0.57% in 2024.
  • Its Return on Equity was 0.57% in Q3 2024, compared to 0.45% in Q2 2024 and 0.54% in Q1 2024.